HCA Healthcare (NYSE:HCA) Given Neutral Rating at JPMorgan Chase & Co.

HCA Healthcare (NYSE:HCA)‘s stock had its “neutral” rating reiterated by equities researchers at JPMorgan Chase & Co. in a research note issued on Tuesday,Benzinga reports. They presently have a $380.00 price objective on the stock. JPMorgan Chase & Co.‘s target price suggests a potential upside of 22.74% from the company’s previous close.

Other analysts have also issued research reports about the company. KeyCorp reduced their target price on HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating for the company in a report on Monday, October 28th. Morgan Stanley assumed coverage on shares of HCA Healthcare in a research note on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 target price on the stock. Raymond James cut shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. StockNews.com cut HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. Finally, Royal Bank of Canada increased their target price on HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a report on Friday, August 23rd. One research analyst has rated the stock with a sell rating, four have issued a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $390.13.

HCA Healthcare Stock Down 1.4 %

Shares of HCA Healthcare stock opened at $309.60 on Tuesday. The stock has a market capitalization of $78.42 billion, a PE ratio of 13.90, a price-to-earnings-growth ratio of 1.21 and a beta of 1.63. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. The company has a 50-day simple moving average of $353.88 and a two-hundred day simple moving average of $358.57. HCA Healthcare has a 52-week low of $263.22 and a 52-week high of $417.14.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, SVP Phillip G. Billington sold 3,897 shares of the stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the transaction, the senior vice president now directly owns 52,702 shares in the company, valued at $18,445,700. This represents a 6.89 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the transaction, the insider now owns 6,843 shares in the company, valued at approximately $2,415,579. This represents a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.60% of the company’s stock.

Institutional Investors Weigh In On HCA Healthcare

A number of hedge funds have recently made changes to their positions in HCA. Terra Nova Asset Management LLC lifted its stake in HCA Healthcare by 0.3% in the 3rd quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company’s stock worth $3,297,000 after purchasing an additional 26 shares in the last quarter. Massmutual Trust Co. FSB ADV increased its stake in shares of HCA Healthcare by 7.4% in the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 421 shares of the company’s stock worth $171,000 after acquiring an additional 29 shares during the last quarter. Waldron Private Wealth LLC grew its holdings in shares of HCA Healthcare by 1.8% in the third quarter. Waldron Private Wealth LLC now owns 1,681 shares of the company’s stock valued at $683,000 after purchasing an additional 29 shares during the period. Brookstone Capital Management raised its stake in HCA Healthcare by 0.7% during the third quarter. Brookstone Capital Management now owns 4,065 shares of the company’s stock worth $1,652,000 after purchasing an additional 30 shares during the period. Finally, UMB Bank n.a. lifted its holdings in HCA Healthcare by 2.4% in the third quarter. UMB Bank n.a. now owns 1,301 shares of the company’s stock valued at $529,000 after acquiring an additional 30 shares during the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.